Intravesical gemcitabine and docetaxel in the treatment of BCG-naïve non–muscle invasive urothelial carcinoma of the bladder: Updates from a phase 2 trial.
Patients and Methods One hundred fourteen women with HER2 -overexpressing metastatic breast cancer were randomized to receive first-line treatment with trastuzumab 4 mg/kg loading dose, followed by 2 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results